Contrast-enhanced [18F] fluorodeoxyglucose-positron emission tomography-computed tomography as an initial imaging modality in patients presenting with metastatic malignancy of undefined primary origin

BACKGROUND: To evaluate the advantages of contrast enhanced F-18-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-contrast enhanced CT [CECT]) when used as an initial imaging modality in patients presenting with metastatic malignancy of undefined primary origin (MUO). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Avani, Srivastava, Madhur Kumar, Pawaskar, Alok Suresh, Shelley, Simon, Elangovan, Indirani, Jain, Hasmukh, Pandey, Somnath, Kalal, Shilpa, Amalachandran, Jaykanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479909/
https://www.ncbi.nlm.nih.gov/pubmed/26170563
http://dx.doi.org/10.4103/0972-3919.158529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479909/
https://www.ncbi.nlm.nih.gov/pubmed/26170563
http://dx.doi.org/10.4103/0972-3919.158529

Ejemplares similares